Oral Peptide Technologies Progressing in the Clinic: Addressing Challenges to Bring New Products to the Market

12:10 - 12:45

  • Importance of non-invasive routes of administration for peptides
  • Focus on oral peptide delivery: marketed products and expectations from the market
  • Main challenges for oral peptide delivery: stability and permeability through the intestinal epithelium
  • Key formulation components in oral peptide technologies progressed in the clinic
  • Lessons learnt from oral peptide clinical studies
  • Anticipating challenges to switch from injection to the oral route
  • Innovative approaches to address the remaining hurdle of low oral peptide absorption

Joel Richard, Senior Vice President, Peptides, Ipsen